Équilibre Biopharmaceuticals Corp. was established as an innovative biopharmaceutical company focused on identifying and developing high-potential drugs for patients who are treatment-resistant or unresponsive to other existing medications. 

Biotechnology

Équilibre Biopharmaceuticals

Équilibre Biopharmaceuticals' headquarters in New York, NY, United States

Philip A. Barach

Meg Dodge

Kevin McCracken

Amy Melsaether

Christopher Thorn

Steven Gordon

Peter Simon

Howard Weiner

Jeffrey Lieberman

Jacqueline French

Theodore Tyberg

Francois Maisonrouge

Matt During

Peter Anton

Christina M. Ramirez

The Leadership Team at Équilibre Biopharmaceuticals is responsible for setting the strategic direction and overseeing the development of innovative treatments for patients with unmet medical needs. Comprising experts in areas such as translational medicine, clinical research, and corporate strategy, this team ensures alignment of research initiatives with business objectives, regulatory compliance, and effective resource allocation to advance the company's mission and growth.

Leadership Team

The Advisory Team at Équilibre Biopharmaceuticals plays a crucial role in guiding the strategic direction of the company's drug development initiatives. Composed of industry experts, this team provides insights on market trends, regulatory challenges, and clinical needs, ensuring that the biopharmaceuticals developed are not only innovative but also aligned with patient and healthcare provider demands. Their expertise supports decision-making and helps optimize the pipeline of treatments for patients with limited therapeutic options.

Advisory Team

The Corporate Strategy and Operations Team at Équilibre Biopharmaceuticals is responsible for shaping the company’s strategic direction and ensuring operational effectiveness. They collaborate on identifying new growth opportunities, managing investor relations, and overseeing project management to streamline drug development processes. By aligning corporate goals with stakeholder needs, the team plays a critical role in advancing innovative therapies for treatment-resistant patients.

Corporate Strategy and Operations Team

The Regulatory and Compliance Team at Équilibre Biopharmaceuticals is responsible for ensuring that all drug development processes adhere to governmental regulations and industry standards. They oversee the submission of regulatory documents, monitor pharmacovigilance activities, and ensure that the company operates within legal parameters to maintain compliance and safeguard patient safety. This team plays a critical role in facilitating the approval of innovative therapies aimed at treatment-resistant conditions.

Équilibre Biopharmaceuticals

Org chart

Board & advisors

Teams

Leadership Team

Advisory Team

Corporate Strategy and Operations Team

Regulatory and Compliance Team

Offices

Équilibre Biopharmaceuticals

Org chart

Board & advisors

Teams

Leadership Team

Advisory Team

Corporate Strategy and Operations Team

Regulatory and Compliance Team

Offices

Related companies